The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

April 22, 2024

Primary Completion Date

August 30, 2025

Study Completion Date

December 30, 2025

Conditions

ObesityDapagliflozin Adverse ReactionWeight LossEffect of Drug

Interventions

DRUG

Dapagliflozin 10mg Tab

Mentioned in detailed description.

DRUG

Metformin 1000 mg (ttd)

A dose of 1000 mg, PO, once daily, given over 8 months period

OTHER

Placebo

a non-medicated pill will be used as a placebol

Trial Locations (1)

Bawsher Health Center, Bawhser

All Listed Sponsors

lead

Oman Ministry of Health

OTHER_GOV

NCT06000462 - The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes | Biotech Hunter | Biotech Hunter